2024-12-31
0000318154
us-gaap:CommonStockMember
2024-01-01
2024-12-31
0000318154
us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember
2024-01-01
2024-12-31
0000318154
us-gaap:CommonStockMember
2024-12-31
0000318154
us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember
2024-12-31
0000318154
us-gaap:RetainedEarningsMember
2024-12-31
0000318154
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-12-31
0000318154
srt:MinimumMember
2024-01-01
2024-12-31
0000318154
srt:MaximumMember
2024-01-01
2024-12-31
0000318154
us-gaap:OperatingSegmentsMember
2024-01-01
2024-12-31
0000318154
us-gaap:OperatingSegmentsMember
2023-01-01
2023-12-31
0000318154
us-gaap:OperatingSegmentsMember
2022-01-01
2022-12-31
0000318154
us-gaap:CorporateNonSegmentMember
2024-01-01
2024-12-31
0000318154
us-gaap:CorporateNonSegmentMember
2023-01-01
2023-12-31
0000318154
us-gaap:CorporateNonSegmentMember
2022-01-01
2022-12-31
0000318154
us-gaap:FairValueAdjustmentToInventoryMember
2024-01-01
2024-12-31
0000318154
us-gaap:FairValueAdjustmentToInventoryMember
2023-01-01
2023-12-31
0000318154
us-gaap:FairValueAdjustmentToInventoryMember
2022-01-01
2022-12-31
0000318154
country:US
amgn:ProliaMember
2024-01-01
2024-12-31
0000318154
us-gaap:NonUsMember
amgn:ProliaMember
2024-01-01
2024-12-31
0000318154
amgn:ProliaMember
2024-01-01
2024-12-31
0000318154
country:US
amgn:ProliaMember
2023-01-01
2023-12-31
0000318154
us-gaap:NonUsMember
amgn:ProliaMember
2023-01-01
2023-12-31
0000318154
amgn:ProliaMember
2023-01-01
2023-12-31
0000318154
country:US
amgn:ProliaMember
2022-01-01
2022-12-31
0000318154
us-gaap:NonUsMember
amgn:ProliaMember
2022-01-01
2022-12-31
0000318154
amgn:ProliaMember
2022-01-01
2022-12-31
0000318154
country:US
amgn:EnbrelMember
2024-01-01
2024-12-31
0000318154
us-gaap:NonUsMember
amgn:EnbrelMember
2024-01-01
2024-12-31
0000318154
amgn:EnbrelMember
2024-01-01
2024-12-31
0000318154
country:US
amgn:EnbrelMember
2023-01-01
2023-12-31
0000318154
us-gaap:NonUsMember
amgn:EnbrelMember
2023-01-01
2023-12-31
0000318154
amgn:EnbrelMember
2023-01-01
2023-12-31
0000318154
country:US
amgn:EnbrelMember
2022-01-01
2022-12-31
0000318154
us-gaap:NonUsMember
amgn:EnbrelMember
2022-01-01
2022-12-31
0000318154
amgn:EnbrelMember
2022-01-01
2022-12-31
0000318154
country:US
amgn:XgevaMember
2024-01-01
2024-12-31
0000318154
us-gaap:NonUsMember
amgn:XgevaMember
2024-01-01
2024-12-31
0000318154
amgn:XgevaMember
2024-01-01
2024-12-31
0000318154
country:US
amgn:XgevaMember
2023-01-01
2023-12-31
0000318154
us-gaap:NonUsMember
amgn:XgevaMember
2023-01-01
2023-12-31
0000318154
amgn:XgevaMember
2023-01-01
2023-12-31
0000318154
country:US
amgn:XgevaMember
2022-01-01
2022-12-31
0000318154
us-gaap:NonUsMember
amgn:XgevaMember
2022-01-01
2022-12-31
0000318154
amgn:XgevaMember
2022-01-01
2022-12-31
0000318154
country:US
amgn:RepathaevolocumabMember
2024-01-01
2024-12-31
0000318154
us-gaap:NonUsMember
amgn:RepathaevolocumabMember
2024-01-01
2024-12-31
0000318154
amgn:RepathaevolocumabMember
2024-01-01